Status:
UNKNOWN
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies.
Detailed Description
This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies. The blood test data will be collected as allowed by th...
Eligibility Criteria
Inclusion
- Patient is Under the care of Texas Cardiac Arrhythmia, and Presenting to the hospital OR Presenting to a clinic conducted by Texas Cardiac Arrhythmia Or
- An employee of Texas Cardiac Arrhythmia Or
- An employee or healthcare professional working with patients receiving cardiac electrophysiology care at a hospital. Or A professional first responder to include Emergency Medical Services (EMS), Police or Fire departments.
Exclusion
- Any person who refuses to undergo study procedures
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2021
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04352764
Start Date
March 27 2020
End Date
January 31 2021
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. David's Medical Center
Austin, Texas, United States, 78705